Adderall
Adderall is a Central Nervous System (CNS) stimulant, approved in the United States and Canada for the management of Attention Deficit Hyperactivity Disorder (ADHD) in children.
On February 9, 2005 Health Canade instructed Shire BioChem Inc. to withdraw Adderall from the Canadian market due to safety information concerning the association of sudden deaths, heart-related deats, and strokes in children and adults taking usual recommended doses of Adderall. The forced withdrawal of Adderall comes as a result of a thorough review of safety information provided by the manufacturer, which indicated that there were 20 international reports of sudden death in patients taking either Adderall or Adderall XR. These deaths were not associated with overdose, misuse or abuse. Fourteen deaths occured in children, and six deaths in adults. There were 12 reports of stroke, two of which occured in children.
ADHD is the most commonly diagnosed mental health disorder in children, according to the American Psychiatric Association. It is often diagnosed once a child hits pres-school and is disruptive in class - anable to sit still, talking incessantly, and having emotional outbursts. While some children see their symptioms fade as they get older, others carry them into adolescence and adulthood.
Links to sites with information on Adderall and ADHD: http://www.adhdhelp.org/AdderallBan.htm
FDA Statement on Adderall
FDA Health Advisory
If you or a loved one would like to discuss your legal rights, please call our law offices or, Click here to request a free legal consultation:
|
